IDEXX Laboratories, Inc. vs Nasdaq Inc — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Nasdaq Inc trades at $90.25 (market cap $51.96B). The key difference: Nasdaq Inc is the larger of the two by market cap, and Nasdaq Inc pays a 1.22% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | NDAQ | |
|---|---|---|
Market Cap | $44.48B | $51.96B |
Sector | Health | Financials |
52-Week High | $766.68 | $100.98 |
52-Week Low | $520.87 | $76.85 |
Enterprise Value | $45.38B | $59.02B |
Dividend Yield | — | 1.22% |
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →